137 related articles for article (PubMed ID: 26126615)
1. Comparison of patient-reported quality of life outcome questionnaire response rates between patients treated surgically for renal cell carcinoma and prostate carcinoma.
Thiel DD; Davidiuk AJ; Broderick GA; Arnold M; Diehl N; Tavlarides A; Custer K; Parker AS
BMC Urol; 2015 Jul; 15():58. PubMed ID: 26126615
[TBL] [Abstract][Full Text] [Related]
2. Comparison of baseline quality of life measures between renal cell carcinoma patients undergoing partial versus radical nephrectomy.
Arnold ML; Thiel DD; Diehl N; Wu KJ; Ames S; Parker AS
BMC Urol; 2013 Oct; 13():52. PubMed ID: 24148752
[TBL] [Abstract][Full Text] [Related]
3. Association of Comorbidity, Age, and Radical Surgical Therapy for Prostate Cancer, Bladder Cancer, and Renal Cell Carcinoma.
Adejoro O; Alishahi A; Konety B
Urology; 2016 Nov; 97():130-137.e1. PubMed ID: 27397095
[TBL] [Abstract][Full Text] [Related]
4. Quality of life of patients undergoing surgical treatment for newly-diagnosed, clinically localized renal cell carcinoma.
Ames SC; Parker AS; Crook JE; Diehl NN; Tan WW; Williams CR; Ames GE
J Psychosoc Oncol; 2011; 29(6):593-605. PubMed ID: 22035533
[TBL] [Abstract][Full Text] [Related]
5. Psycho-social well-being and general health status after surgical treatment for localized renal cell carcinoma.
Ficarra V; Novella G; Sarti A; Novara G; Galfano A; Cavalleri S; Artibani W
Int Urol Nephrol; 2002; 34(4):441-6. PubMed ID: 14577481
[TBL] [Abstract][Full Text] [Related]
6. Baseline and follow-up association of the MAX-PC in Men with newly diagnosed prostate cancer.
Tavlarides AM; Ames SC; Thiel DD; Diehl NN; Parker AS
Psychooncology; 2015 Apr; 24(4):451-7. PubMed ID: 24953309
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life, personality and choice of coping are related in renal cell carcinoma patients.
Beisland E; Beisland C; Hjelle KM; Bakke A; Aarstad AK; Aarstad HJ
Scand J Urol; 2015; 49(4):282-9. PubMed ID: 25515950
[TBL] [Abstract][Full Text] [Related]
8. Compared with radical nephrectomy, nephron-sparing surgery offers a long-term survival advantage in patients between the ages of 20 and 44 years with renal cell carcinomas (≤4 cm): an analysis of the SEER database.
Daugherty M; Bratslavsky G
Urol Oncol; 2014 Jul; 32(5):549-54. PubMed ID: 24495447
[TBL] [Abstract][Full Text] [Related]
9. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the association of prostate cancer-specific anxiety with sexual function, depression and cancer aggressiveness in men 1 year following surgical treatment for localized prostate cancer.
Tavlarides AM; Ames SC; Diehl NN; Joseph RW; Castle EP; Thiel DD; Broderick GA; Parker AS
Psychooncology; 2013 Jun; 22(6):1328-35. PubMed ID: 22855322
[TBL] [Abstract][Full Text] [Related]
11. Oncological outcome of minimum incision endoscopic radical nephrectomy for pathologically organ confined renal cell carcinoma.
Iimura Y; Kihara K; Saito K; Masuda H; Kobayashi T; Kawakami S
Int J Urol; 2008 Jan; 15(1):44-7. PubMed ID: 18184170
[TBL] [Abstract][Full Text] [Related]
12. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
[TBL] [Abstract][Full Text] [Related]
14. A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma.
Bianchi M; Gandaglia G; Trinh QD; Hansen J; Becker A; Abdollah F; Tian Z; Lughezzani G; Roghmann F; Briganti A; Montorsi F; Karakiewicz PI; Sun M
Urol Oncol; 2014 Jan; 32(1):46.e1-7. PubMed ID: 24054864
[TBL] [Abstract][Full Text] [Related]
15. Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005-2010: a population-based study from the national Swedish kidney cancer register.
Thorstenson A; Bergman M; Scherman-Plogell AH; Hosseinnia S; Ljungberg B; Adolfsson J; Lundstam S
Scand J Urol; 2014 Jun; 48(3):231-8. PubMed ID: 24666102
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life in long-term survivors after renal cancer treatment.
Beisland C; Beisland E; Hjelle KM; Bostad L; Hjermstad MJ; Aarstad AK; Aarstad HJ
Scand J Urol; 2014 Feb; 48(1):52-64. PubMed ID: 23883326
[TBL] [Abstract][Full Text] [Related]
17. Retroperitoneoscopic versus open surgical radical nephrectomy for large renal cell carcinoma in clinical stage cT2 or cT3a: quality of life, pain and reconvalescence.
Dillenburg W; Poulakis V; Skriapas K; de Vries R; Ferakis N; Witzsch U; Melekos M; Becht E
Eur Urol; 2006 Feb; 49(2):314-22; discussion 322-3. PubMed ID: 16377073
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous cryoablation of renal masses: Washington University experience of treating 129 tumours.
Kim EH; Tanagho YS; Bhayani SB; Saad NE; Benway BM; Figenshau RS
BJU Int; 2013 May; 111(6):872-9. PubMed ID: 23145500
[TBL] [Abstract][Full Text] [Related]
19. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.
Leibovich BC; Blute M; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2004 Mar; 171(3):1066-70. PubMed ID: 14767272
[TBL] [Abstract][Full Text] [Related]
20. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
